Perioperative systemic treatments in renal cell carcinoma.

Goswamy, Rohit; Kalemoglu, Ecem; Master, Viraj; Bilen, Mehmet Asim

Goswamy, Rohit; Kalemoglu, Ecem; Master, Viraj; Bilen, Mehmet Asim.

Afiliación

Goswamy R; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States.
Kalemoglu E; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States.
Master V; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, United States.
Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States.

Front Oncol ; 14: 1362172, 2024.

Article en En | MEDLINE | ID: mdl-38841158

ABSTRACT

ABSTRACT

In this review, we aim to provide a comprehensive assessment of the evolving landscape of the perioperative management in renal cell carcinoma (RCC), emphasizing its dynamic and intricate nature. We explore academic and clinical insights into the perioperative treatment paradigm of RCC. Up-to-date treatment options are discussed and the evolving role of neoadjuvant and adjuvant therapy in RCC is highlighted.

Palabras clave

RCC (Renal Cell Carcinoma); adjuvant; cancer; kidney cancer; neoadjuvant; outcomes; renal cell carcinoma; review

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google